CRYO-CELL INTERNATIONAL, INC. Debt Instrument, Unamortized Discount (Premium) and Debt Issuance Costs, Net
CRYO-CELL INTERNATIONAL, INC. (CCEL) had Debt Instrument, Unamortized Discount (Premium) and Debt Issuance Costs, Net of $117.10 thousand as of 2026-05-31, per its 10-Q filed 2026-07-15.
Financial Statements › Notes › Debt
us-gaap:DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet · last filed 2026-07-15
- 2026-05-31: Debt Instrument, Unamortized Discount (Premium) and Debt Issuance Costs, Net $117.10K.
- 2026-02-28: Debt Instrument, Unamortized Discount (Premium) and Debt Issuance Costs, Net $122.21K.
- 2025-11-30: Debt Instrument, Unamortized Discount (Premium) and Debt Issuance Costs, Net $127.34K.
- 2025-05-31: Debt Instrument, Unamortized Discount (Premium) and Debt Issuance Costs, Net $137.70K.
| Period end | Debt Instrument, Unamortized Discount (Premium) and Debt Issuance Costs, Net |
|---|---|
| 2026-05-31 | $117.10K 10-Q · filed 2026-07-15 |
| 2026-02-28 | $122.21K 10-Q · filed 2026-04-14 |
| 2025-11-30 | $127.34K 10-K · filed 2026-02-27 |
| 2025-05-31 | $137.70K 10-Q · filed 2025-07-15 |
| 2025-02-28 | -$142.92K 10-Q · filed 2025-04-14 |
| 2024-11-30 | $148.17K 10-K · filed 2025-02-28 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| MANGOCEUTICALS, INC. (MGRX) | United States | $0.010B | -0.43 |
| BioRestorative Therapies, Inc. (BRTX) | United States | $0.064B | |
| Park Dental Partners, Inc. (PARK) | United States | $0.094B | |
| VIEMED HEALTHCARE, INC. (VMD) | United States | $0.336B | 29.92 |
| agilon health, inc. (AGL) | United States | $1.272B | -7.76 |
| Progyny, Inc. (PGNY) | United States | $1.994B | 28.37 |
| Sotera Health Co (SHC) | United States | $5.271B | 30.96 |
| DAVITA INC. (DVA) | United States | $11.147B | 16.80 |